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1. Introduction 
The attainment of more efficient health care systems has always been a central goal for policy 
makers. Also due to the 2007/2008 economic crisis, the need to rationalize public expenditure (i.e., 
spending review policies) across all government functions has been furtherly exogenously 
reinforced. Considered that during the last forty years health care expenditure (as a share of the 
GDP) has rapidly increased up to 13.3% in 2016 in OECD countries, the achievement of a more 
sustainable health care system has become a priority target for policy makers. 
On this ground, the aim of our work is twofold: a) to pin down the main determinants of health 
care systems efficiency (HHS) by focusing on the impact of discretionary and non-discretionary 
factors; b) to highlight areas of possible efficiency enhancements.  
A substantial body of empirical literature focuses on the measurement of health sector performance 
across different OECD (see Mobley and Magnussen 1998, Hollingsworth 2003, Osterkamp 2004, 
Retzlaff-Roberts et al. 2004, Bhat 2005, Afonso et al. 2005, Grosskopf et al. 2006, Siciliani 2006, 
Hollingsworth 2008, Spinks and Hollingsworth 2009, Adam et al. 2011, Mirmirani and Lippmann 
2011, Sinimole 2012, Cetin and Bahce, 2016, Carrillo and Jorge 2017, Ozcan and Khushalani 
2017),  EU (see Afonso et al. 2010a, Jeremic et al. 2012 and Del Rocio Moreno-Enguix et al. 
2018) and emerging countries (see Herrera and Pang 2005 and Afonso et al. 2010a) using a wide 
set of socio-economic indicators. In terms of methodology, most of this stream of literature 
estimates the extent of slack in government expenditures by employing, alternatively or in 
combination, Free Disposable Hull – FDH (see Deprins et al. 1984) and Data Envelopment 
Analysis – DEA (see Farrel 1957 and Charnes et al. 1978) nonparametric production frontier 
techniques, ensuring the least amount of possible restrictions on data. Besides this stream of works, 
others add parametric techniques (i.e., stochastic frontier analysis, SFA) to former nonparametric 
methods (see Greene 2004, Greene 2010, Kumbhakar 2010, Varabyova and Schreyögg 2013, de 
Cos and Moral-Benito 2014 and Hamidi and Akinci 2016). Other authors (see Spinks 2009), 
however, highlight the possible pitfalls and limitations that affect such methods. 
Closer to our approach, in terms of methodology adopted and research question raised, is a second 
stream of literature (see Puig-Junoy 1998, Evans et al. 2001, Afonso and St. Aubyn 2011, Wranik 
2012 and Hadad et al. 2013) that employs a two-stage estimation strategy. This type of analysis is 
grounded on a combination of nonparametric and parametric methods: in the first stage, the relative 
production efficiency analysis is conducted through non-parametric techniques, such as FDH and 
DEA; while in the second-stage, Tobit, Truncated and Bootstrap regression analysis is adopted in 
order to investigate the relation between health care systems efficiency scores and “environmental” 
variables. 
Varabyova and Müller (2016) conducted a systematic review and a meta-analysis on the works 
that investigate the efficiency of health care systems in OECD countries, assessing that 
international comparisons of health care system efficiency can potentially provide a rich source of 
evidence and therefore influence policy decisions by outlining directions for reforms. They 
conclude that measuring the efficiency of health care provision by considering a comparable 
sample of countries is useful to detect the areas in which there is an improvement potential in the 
use of resources. 
Among the others, Hadad et al. (2013), using a panel of 31 OECD countries, employs a two-stage 
DEA and multivariate regression analysis. In the first stage, the HSS is assessed by relying on two 
different input/output specifications, based on, respectively, relative more discretionary and non-
discretionary inputs. In the second stage, through a multivariate regression analysis he checks if 
institutional arrangements, population habits and socioeconomic determinants reveal an 
explanatory capacity over HHS. The main findings exhibit an ambiguous incidence of the socio-
economic and environmental regressors. 
Very close to ours, Afonso e St. Aubyn (2011), spanning through a panel of 21 OECD countries, 
employ a two stage DEA and Tobit/Bootstrap estimation strategy. In the second stage, they mainly 
investigate the incidence exerted by non-discretionary variables on HHS. The main findings reveal 
that inefficiency in health is strongly explained by factors that in a short period span are not under 
the control of governments. 
In this context, we perform a two-stage FDH/DEA and Tobit analysis, also adopting the Simar and 
Wilson (2007) algorithm#1 bootstrap procedure, in order to ensure non-biased estimates. We 
highlight the main differences and improvements with respect to previous literature. With regard 
to the first stage, we employ one input, public health expenditure, measured in monetary terms, as 
in Afonso et al. (2005) and Gupta and Verhoeven (2001) but differently from Afonso and St. Aubyn 
(2005), where inputs are measured in physical terms. As for the output measure, we build a new 
health performance indicator (HPI) that is composed, besides health status indicators (i.e., infant 
mortality rate and life expectancy at birth), as in Afonso and St. Aubyn (2011), Afonso et al. (2005), 
and Gupta and Verhoeven (2001), also by a health treatment variable (i.e., hospital discharges). 
With respect to the second stage, we extend the analysis of the role of non-discretionary factors 
(see Afonso and St. Aubyn 2011), including new variables such as vaccine coverage for elderly 
individuals and weather temperature, besides the more traditional life-style habits controls. Our 
main findings reveal that vaccine coverage, weather temperature, GDP and tobacco consumption 
are strongly correlated to inefficiencies in the health sector. In terms of policy implications, with 
respect to discretionary inputs, our results confirm the existence of a wide room for efficiency 
improvements.  
The remainder of the manuscript is structured as follows. Section 2 reports data and variables used 
in the analysis. Section 3 describes the methodology and the estimation strategy. Section 4 presents 
the estimation results. Finally, section 5 draws the main concluding remarks. 
 
2. Data section 
We use data from a panel of 30 OECD countries for a period of 11 years, from 2005 to 2015. The 
sample is composed by: Australia, Austria, Belgium, Czech Republic, Denmark, Estonia, Finland, 
France, Germany, Greece, Hungary, Iceland, Ireland, Israel, Italy, Japan, Korea, Latvia, 
Luxembourg, Netherlands, New Zealand, Poland, Portugal, Slovak Republic, Slovenia, Spain, 
Sweden, Switzerland, Turkey, United Kingdom. We use averages, instead of higher frequency 
data; this is preferable for different reasons. First, the effect of some policies is not immediately 
observable, but may take time to settle in. Second, most of the measures of government activity 
have long-run effects. 
For the first stage of the analysis (FDH analysis and DEA) we use the variables (source: OECD) 
reported in Table I. 
 
 
 
 
 
 
 
 
 
Table I: – DEA/FDH variables description and sources 
Variables Description Source 
Infant Mortality Rate 
(IMR) 
Number of deaths under one year of age occurring among the live births in a 
given geographical area during a given year, per 1,000 live births occurring 
among the population of the given geographical area during the same year. 
In other terms, IMR is equal to (Number of children who died before 12 
months) / (Number of born children) x 1,000 
OECD 
Life Expectancy at birth 
(LE) 
How long, on average, a new-born can expect to live, if current death rates 
do not change. This indicator is measured in years 
OECD 
Hospital Discharge rates 
(HD) 
Number of patients who leave a hospital after receiving care. Hospital 
discharge is defined as the release of a patient who has stayed at least one 
night in hospital. It includes deaths in hospital following inpatient care. 
Same-day discharges are usually excluded. This indicator is measured per 
100,000 inhabitants 
OECD 
Health Expenditure (HE) 
Final consumption of health care goods and services (i.e., current health 
expenditure) including personal health care (curative care, rehabilitative care, 
long-term care, ancillary services and medical goods) and collective services 
(prevention and public health services as well as health administration) but 
excluding spending on investments. Health care is financed through a mix of 
financing arrangements including government spending and compulsory 
health insurance (“Government/compulsory”) as well as voluntary health 
insurance and private funds such as households’ out-of-pocket payments, 
NGOs and private corporations (“Voluntary”). This indicator is presented as 
a total and is measured in USD per capita (using economy-wide PPPs) 
OECD 
 
The first three variables are interpreted as output, reflecting health status and health outcomes; per 
capita Health Expenditure represents our input. 
Table II shows the descriptive statistics of the variables used in the FDH analysis and in the DEA. 
 
Table II: Descriptive statistics for the non-parametric analysis 
 Mean SD Max. Min. 
Infant Mortality Rate (IMR) 3.47 1.61 10.70 1.60 
Life Expectancy at birth (LE) 80.74 2.32 83.90 74.60 
Hospital Discharge rates (HD) 16475.94 3738.21 25581.10 10917.40 
Health Expenditure (HE) 3097.67 1334.77 6147.97 856.95 
Discounted Health Expenditure (DHE) 2706.20 1031.34 4918.38 771.26 
Source: OECD and World Bank. 
Note: all variables are collected for years 2005 and 2015 and averaged, except for IMR, 
available until 2014 for Korea and until 2013 for New Zealand; HD, available until 2014 
for Australia, France e New Zealand and until 2010 for Greece and Netherlands. 
 
The econometric specification in the second stage of the analysis grounds on the set of variables 
reported in Table III. 
 
 
 
 
 
 
Table III: – Econometric estimations variables description and sources 
Variables Description and motivation Source 
Gross 
Domestic 
Product 
(GDP) 
Measured as PPP per capita GDP averaged over the period 2005-2015 (OECD data); the 
correlation sign of this variable with efficiency is ambiguous; per capita GDP can be 
positively correlated to the efficiency score since it proxies the physical capital stock, which 
favours production efficiency as well as monitoring of policymakers (see Afonso and St. 
Aubyn 2011); or negatively related, via the Balassa (1964)-Samuelson (1964) effect. 
OECD 
Weather 
Temperature 
(TEMP) 
Measured as the average temperature over the period 2006-2010. This variable is a country 
specific exogenous variable that may be positively correlated to life expectancy at birth 
(World Bank, Climate change knowledge portal). Not included in previous health care 
efficiency empirical papers. 
World 
Bank 
Red Tape 
(RT) 
Measured as the average value of the survey indicator GCI over the period 2007-2015. This 
indicator measures the slowness of bureaucracy in implementing public policies and it can 
be used as a proxy for institutional framework inefficiency. 
GCI
1
 
Vaccine coverage – Preventive health care  
Influenza 
Vaccine 65+ 
(VAX65) 
Measured as the percentage of the population aged 65 and older who has received an annual 
flu vaccine. This variable can also be a proxy for the willingness of elderly individuals to 
demand preventive health care (OECD data, https://data.oecd.org/health care/influenza-
vaccination-rates.htm). 
OECD 
Diphtheria, 
Tetanus, and 
Pertussis 
Vaccine 
(DTP) 
Measured as the percentage of children who receive at least one dose of DTP vaccine at 
around age 1. This variable (used also in Herrera and Pang 2005) accounts for preventive 
health care treatments of infant individuals (OECD data, https://data.oecd.org/health 
care/child-vaccination-rates.htm).  
OECD 
Lifestyle factors   
Tobacco 
(TOB) 
Measured as the percentage of population aged 15 years old and over reporting to be daily 
smokers (OECD Data, https://data.oecd.org/healthrisk/daily-smokers.htm). This variable 
exerting a negative impact on LE is expected to be inversely related to efficiency scores, 
as in previous works (see Afonso and St. Aubyn 2011). 
OECD 
Obesity 
(OB) 
People with excessive weight present health risks because of the high proportion of body 
fat. This indicator is derived from "self-reported" data (estimates of height and weight from 
population-based health interview surveys) and is measured as a percentage of the 
population aged 15 years and older.  Lifestyle regressor included in previous works (see 
Afonso and St. Aubyn 2011) for testing the effect on DEA/FDH efficiency scores (OECD 
Data, https://data.oecd.org/healthrisk/overweight-or-obese-population.htm). 
OECD 
 
These variables, that might be correlated to efficiency, are non-discretionary or exogenous factors, 
since they cannot be changed by the policymaker in the short run. 
 
 
 
 
 
 
                                                             
1
 The GCI measures the performance of the public sector and varies from zero (worst) to 100 (best). It analyses competitiveness 
along 12 pillars: institutions, infrastructure, macroeconomic environment, health and primary education, higher education and 
training, goods market efficiency, labour market efficiency, financial market development, technological readiness, market size, 
business sophistication and innovation. 
These are, in turn, organized into three sub-indices in line with three main stages of development: basic requirements, efficiency 
enhancers, and innovation and sophistication factors. The three sub-indices are given different weights in the calculation of the 
overall index, depending on each economy's stage of development, as proxied by its GDP per capita and share of exports represented 
by mineral raw materials (https://tcdata360.worldbank.org/indicators/gci?country=BRA&indicator=631&viz=line_chart&years=2007,2017). 
Table IV: Descriptive statistics for the regressors of the econometric specification 
 Mean SD Max. Min. 
Gross Domestic Product (GDP) 35670.67 13351.51 87881.00 18195.00 
Influenza Vaccine 65+ (VAX65) 41.57 22.78 81.70 1.60 
Weather Temperature (TEMP) 10.35 4.38 21.92 2.32 
Diphtheria, Tetanus, and Pertussis Vaccine (DTP) 96.17 2.26 99.00 92.00 
Red Tape (RT) 3.28 0.64 4.49 2.09 
Tobacco (TOB) 19.46 4.23 27.30 10.90 
Obesity (OB) 16.27 5.17 30.00 2.80 
Source: OECD (GDP, VAX65, DTP, TOB, OB), World Economic Forum (RT) and World Bank 
(TEMP). 
Note: all variables are collected for years 2005 and 2015 and averaged, with the exception of (i) 
TOB, available until 2014 for Austria, Belgium, Estonia, France, Greece, Hungary, Israel, Latvia, 
Poland, Portugal, Slovak Republic, Slovenia, Spain, and Turkey, until 2013 for Australia and 
Germany, and until 2012 for Switzerland; (ii) OB, available until 2014 for Austria, Belgium, 
Czech Republic, Denmark, Estonia, France, Germany, Greece, Hungary, Israel, Latvia, 
Luxembourg, Poland, Portugal, Slovak Republic, Slovenia, Spain, Turkey, and United Kingdom 
and until 2007 for Australia; (iii) VAX65, available until 2014 for Austria, Czech Republic, 
Greece, Japan, Poland, and Turkey, until 2013 for Belgium, until 2012 for Switzerland and until 
2009 for Australia.  
 
3. Methodology and estimation strategy 
In order to pin down the determinants of health sector efficiency, our approach entails a two-stage 
estimation strategy (see Afonso et al. 2005, Afonso and St. Aubyn 2005, Afonso et al. 2010a and 
2010b, and Afonso and St. Aubyn 2011). In the first stage, we construct a Health Performance 
Indicator (HPI), based on IMR, LE and HD variables, that represents our output indicator, against 
which we measure countries’ relative efficiency in the use of the input variable (HE). We adopt a 
non-parametric approach (FDH analysis and DEA). 
In the second stage, we implement a censored Tobit regression estimation in order to investigate 
the causal relationship between the estimated countries' efficiency scores and a set of institutional, 
socio-economic, lifestyle and geographical characteristics.  
Furtherly, we estimate the Simar and Wilson (2007) algorithm#1 in order to account for the 
possibility of a correlation pattern among the estimated efficiency scores: errors may not be iid 
across countries and efficiency scores could thus take value 1, according to FDH and DEA linear 
formulation, with zero probability. 
 
3.1 First stage: Efficiency analysis 
3.1.1 The Health Performance Indicator (HPI) 
We start by building up a Health Performance Index (HPI)
2
,
  
summarizing the output of health 
policies. As in Afonso and St Aubyn (2011) we consider health status indicators (IMR and LE); 
however, we also add a health treatment indicator (HD) as a proxy for patients’ hospital care. To 
ensure that the highest values of the indicator are representative of the best performance, we 
                                                             
2
 We use the term performance to refer to the effectiveness of the health care service provision (i.e., the outcome achieved by the 
countries included in our panel). The concept of performance is a multidimensional concept related to both efficiency and 
effectiveness of public policies. We use the term performance to summarize the outcome achieved in the health sector by the 
countries selected for our analysis. 
transform primary data on Infant Mortality Rates into Infant Survival Rates (ISR) by applying the 
following expression: 
ISR = (1000-IMR)/IMR                                                     (1) 
which represents the ratio of children that survived the first year to the number of children that 
died. 
Following Antonelli and De Bonis (2017, 2018 and 2019), each variable is normalized in the 
following way:
3
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where xi,j is the value of the output-variable j in country i, while xi,minj and xi,maxj represent, 
respectively, the minimum and maximum values for the same output-variable within the group of 
the 30 OECD countries. Each normalized variable ranges between 0 and 1 and higher values 
indicate a better relative performance. Finally, an overall indicator for the health sector 
performance is obtained as the sum of the partial indicators coherently with the existing literature 
(see Afonso and St Aubyn 2011). For country i we thus have: 
���$ =  �$'
(
')*                                                                 (3) 
 
3.1.2  FDH and DEA approach 
We now turn to the measure of health sector efficiency employing the FDH and DEA
4
 non-
parametric methods. Both techniques allow to build a production possibility frontier, that enables 
the ranking of the countries’ efficiency performances. DEA adds the hypothesis of convexity of 
the production possibility frontier. The performance achieved in the health sector (HPI) is the 
output, while health expenditure (HE) is the input.  
We test, for each i country, the following general functional relationship: 
���$ = � ��$ , � = 1,… ,30                                            (4) 
with HPIi < f(HEi) denoting that country i is inefficient. 
Countries on the frontier exhibit the highest possible level of performance, given the level of health 
expenditure (alternatively, they use the lowest level of expenditure to achieve a given level of 
performance); in other words, there exist no other countries that obtain the same level of 
performance with a lower level of expenditure. Countries on the frontier are assigned input and 
output efficiency scores of 1; against them, one can measure the relative input and output 
inefficiency of countries that lie inside the frontier, thus obtaining a relative ranking. 
So, for each country, that represents a single decision-making unit (DMU) in the FDH/DEA 
method, the linear programming model is configured as to determine the level of input contracted 
efficiently in order to achieve the same output level.
5
 We focus our attention on the input-oriented 
specification, since in many countries public finance constraints often impose a spending review 
process to limit resource waste in the health sector. 
Then, the efficiency score for the i-th DMU is given by the solution of the following problem:
6
 
                                                             
3
 We apply the same methodology used for the Human Development Indices. Methodological notes are available at the following 
link: http://hdr.undp.org/en/content/calculating-indices. 
4
 See Deprins et al. (1984) for the Free Disposal Hull (FDH) method, and Farrell (1957) and Charnes et al. (1978) for the Data 
Envelopment Analysis (DEA). 
5
 This is the input-oriented formulation of the problem. The output-oriented approach of the linear programming problem is 
configured to determine a DMU’s potential output given its inputs. 
6
 The problem is an input-oriented specification for variable returns to scale (vrs) in the equivalent envelopment form of the original 
linear programming problem as in Charnes et al. (1978). 
���56 7 �$ 
subject to ��$ + �� ≥ 0                                                     (5) 
−�$ + �� ≥ 0 
�1A� = 1 
� ≥ 0 
where X and Y are, respectively, the output matrix (m x n) and the input matrix (k x n), δ is the 
scalar ≤1 representing the distance between each country i and the frontier, defined as a linear 
combination of the best practice observations. The vector λ is a vector of constants representing 
the weights to be used to compute the linear combinations of the peers for the i-th country, thus 
indicating the attainable position on the frontier with an improvement of its efficiency. Finally, in 
the DEA case, if health has an inverted U-shape relationship with respect to health expenditure 
(see Culyer and Wagstaff 1993), the constraint n1'λ = 1 guarantees convexity of the frontier, 
accounting for variable returns to scale (see Banker et al. 1984).  
 
3.2 Second stage: TOBIT regression estimations 
As a second step of the empirical investigation, we assess the effects of some environmental and 
life-style variables on efficiency. The analysis considers “non-discretionary” variables as most of 
the literature on efficiency of the public sector (see Evans et al. 2001, Afonso et al. 2005, Afonso 
and St. Aubyn 2005, Afonso et al. 2010a and 2010b). Actually, variables other than the health 
expenditure level (our input) might be correlated with efficiency (our output), thus contributing to 
explain differences in the level of output (HPI) obtained per unit of money used, or, in other words, 
to pin down the reasons why some countries appear to need more resources than others do to obtain 
the same level of performance. The inclusion of “non-discretionary” variables in the econometric 
strategy is mainly due to the evaluation of their exogenous influence on the design and the effects 
of social policies (see Ruggiero 2004). 
To this purpose, we start by estimating a Tobit regression model, since the distribution of the 
efficiency scores is not normal and is censored at 1 (as for its maximum value), grounding on the 
following specification: 
EFFi = β1GDPi+β2VAX65i +β3TEMPi+β4DTPi+β5RTi+ β6TOBi+β7OBi+ Ɛi, i = 1, … ,30            (6) 
where EFFi is the vector of the FDH input efficiency scores
7
 while the regressors, on the right-
hand side, have been described in section 3. The βi are the coefficients to be estimated and Ɛi is the 
errors' vector. On the ground of previous empirical research and theoretical hypotheses, we expect 
a positive sign for DTP, and VEG; a negative sign for RT, TOB and OB; while previous results are 
more ambiguous for GDP. Moreover, we introduce two new variables, TEMP and VACC65, in 
order to verify country specific non-discretionary controls related to climate environment and 
preventive care for elderly individuals. 
The two-stage FDH/DEA and Tobit method, however, can be biased in small samples. As pointed 
out by Simar and Wilson (2007), the estimation through DEA/FDH of the distance (HPIi, HEi) is 
affected by finite sample bias and efficiency scores are biased towards 1. Thus, performance scores 
are jointly calculated and the error term in (6) is serially correlated; moreover, non-discretionary 
variables are correlated to the efficiency scores and the error term.  
                                                             
7
 We use FDH input efficiency scores because in most of the analysed OECD countries the political debate on the health system is 
mainly focused on policy options that rely on expenditure’s cuts (i.e., our input). Moreover, we prefer FDH to DEA since it is 
grounded on less restrictive assumptions. Results, however, do not change significantly by using output efficiency scores and/or 
the DEA method. 
In order to deal with these pitfalls and possible misleading outcomes, we switch to bootstrapping 
methods, that, entailing an alternative data generating process for the estimation of the parameters, 
grants the attainment of unbiased results. In this vein, we employ one of the bootstrap estimation 
procedures proposed by Simar and Wilson (2007), namely algorithm #1 with 1,000 replications: 
the influence of non-discretionary inputs is estimated by a truncated linear regression and the 
significance of estimated coefficients is assessed by bootstrapping. This step is important in our 
strategy ensuring a robustness check of previous Tobit estimation outcomes. 
 
4. Empirical analysis and robustness check 
We start our empirical analysis calculating the values of the HPI for the year 2015, reported in 
Table V. The final values are characterized by a high degree of heterogeneity within the group of 
countries considered, ranging from 0.7882 (Turkey) to 2.1916 (Slovenia). The sample of countries 
appears to be balanced in relation to the performance indicator: 15 countries have an HPI higher 
than the average value; Belgium is in line with the average; the remaining 14 countries are placed 
under the average. 
We then move to investigate the relationship between the output (as summarized by the HPI) and 
the input (represented by HE) of countries' health sectors calculating their efficiency scores. We 
use the average values of health expenditure over the period 2005-2015 to account for possible 
lagged effects of expenditure on output. Table VI summarizes the input-oriented efficiency scores. 
The efficiency analysis shows that Estonia, Korea, Latvia, Poland, Slovenia and Turkey are on the 
FDH frontier. Marginal differences characterize the DEA analysis due to the additional hypothesis 
of convexity.
8
 On average, the efficiency score is about 0.7 for the FDH analysis and 0.6 for the 
DEA. This means that, on average, countries in the sample could obtain the same performance by 
reducing the input (HE) by about 30-40%. For the inefficient countries, the FDH scores ranges 
from 0.299 and 0.978 and the DEA scores from 0.270 and 0.940. 
Moreover, according to their position with respect to the average per capita HE of our sample, we 
cluster two groups of countries (Table VI). With both methods we note that countries with per 
capita HE below the average displace relative higher efficiency scores with respect to the sample. 
The opposite is true when considering countries with higher than average per capita HE. This result 
can motivate further considerations in terms of the trade-off between efficiency and equity. As in 
van Doorslaer et al. (2000), this could reveal that countries with higher HE ensure a more capillary 
extension of the health care services. 
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 Note that in the DEA frontier a smaller number of countries is located on the frontier. 
Table V: The Health Performance Index (2015) 
Countries LE ISR HD HPI 
Australia 0.8495 0.4121 0.4475 1.7090 
Austria 0.7204 0.4311 1 2.1515 
Belgium 0.6989 0.3943 0.3863 1.4795 
Czech Republic 0.4409 0.5767 0.6629 1.6805 
Denmark 0.6667 0.3326 0.2631 1.2624 
Estonia 0.3333 0.5767 0.4248 1.3348 
Finland 0.7527 0.9308 0.3892 2.0727 
France 0.8387 0.3326 0.5075 1.6789 
Germany 0.6559 0.3943 0.9968 2.0470 
Greece 0.6989 0.2945 0.5952 1.5887 
Hungary 0.1183 0.2721 0.6199 1.0103 
Iceland 0.8495 0.6793 0.0319 1.5607 
Ireland 0.7419 0.3775 0.2146 1.3340 
Israel 0.8065 0.4311 0.3391 1.5766 
Italy 0.8602 0.4729 0.0640 1.3971 
Japan 1.0000 0.7200 0.1020 1.8220 
Korea 0.8065 0.5210 0.3748 1.7022 
Latvia 0.0000 0.2830 0.5310 0.8140 
Luxembourg 0.8387 0.4961 0.2489 1.5837 
Netherlands 0.7527 0.3943 0.0497 1.1966 
New Zealand 0.7634 0.2004 0.2364 1.2002 
Poland 0.3226 0.2945 0.4119 1.0290 
Portugal 0.7097 0.4729 0 1.1826 
Slovak Republic 0.2258 0.1931 0.6230 1.0419 
Slovenia 0.6774 1 0.5142 2.1916 
Spain 0.9032 0.5210 0.0353 1.4595 
Sweden 0.8280 0.5767 0.2997 1.7044 
Switzerland 0.9032 0.3066 0.4248 1.6346 
Turkey 0.3656 0 0.4226 0.7882 
United Kingdom 0.6882 0.3066 0.1550 1.1497 
Note: our elaboration on OECD Health Statistics (2015). For the 
calculation of ISR we used 2014 data for Korea and 2013 data 
for New Zealand. For hospital discharges we used 2014 data for 
Australia, France and New Zealand; 2010 data for Greece and 
the Netherlands. 
Table VI: FDH and DEA: input-oriented efficiency scores (2015) 
Countries FDH  DEA  
Australia 0.648  0.496  
Austria 0.553  0.543  
Belgium 0.487  0.392  
Czech Republic 0.978  0.907  
Denmark 0.324  0.308  
Estonia 1  1  
Finland 0.692  0.652  
France 0.496  0.459  
Germany 0.542  0.504  
Greece 0.778  0.678  
Hungary 0.804  0.663  
Iceland 0.528  0.452  
Ireland 0.318  0.318  
Israel 0.897  0.775  
Italy 0.627  0.474  
Japan 0.692  0.568  
Korea 1  0.940  
Latvia 1  0.795  
Luxembourg 0.311  0.270  
Netherlands 0.299  0.271  
New Zealand 0.466  0.423  
Poland 1  0.838  
Portugal 0.554  0.495  
Slovak Republic 0.778  0.620  
Slovenia 1  1  
Spain 0.687  0.546  
Sweden 0.580  0.443  
Switzerland 0.332  0.299  
Turkey 1  1  
United Kingdom 0.439  0.383  
Average EFF all countries 0.660  0.584  
Average EFF by countries’ cluster     
Countries with HE < average HE 0.838  0.719  
Countries with HE > average HE 0.483  0.449  
 
Finally, we estimate a Tobit model to disentangle potential heterogeneity across countries that may 
affect the efficiency scores. We consider variables, other than the level of expenditure, that might 
affect efficiency though being beyond the policymakers’ control in the short and medium run. 
Results are reported in Table VII. 
 
 
 
 
 
 
 
 
 
 
 
Table VII: Regression results. Dependent variable: FDH input-oriented efficiency scores 
Tobit regression with FDH efficiency scores 
 
Model 1 
FDH 
Model 2 
FDH 
TEMP 
0.0189431** 
(-0.0273) 
0.0244593*** 
(-0.0034) 
VAX65 
-0.00418829*** 
(-0.0044) 
-0.00621110*** 
(-0.0002) 
GDP 
-1.27667e-05*** 
(0.0000) 
-1.44601e-05*** 
(0.0000) 
DTP 
0.0230867* 
(-0.0815) 
0.0277396** 
(-0.0349) 
RT 
-0.108537* 
(-0.0877) 
-0.105638* 
(-0.0671) 
TOB  
-0.0169265** 
(-0.0356) 
OB  
-0.00831111* 
(-0.0876) 
Const. 
-1.4823 
(-0.2780) 
-1.3682 
(-0.2860) 
sigma 
0.131939*** 
(0.0000) 
0.117690*** 
(0.0000) 
Obs. 30 30 
Note: Robust standard errors in parentheses *** p<0.01, ** p<0.05, * p<0.1 
 
In Model 1 we first introduce variables that are related to country specific socio-economic and 
geographical characteristics: GDP, VAX65, DTP, TEMP and RT. The outcomes of the estimation 
show that GDP exerts a negative impact (strongly significant, at the 1% level) on public health 
sector efficiency. This finding can be interpreted through the Balassa (1964) - Samuelson (1964) 
effect according to which prices of non-tradable goods (i.e., most of government services such as 
health and education)
9
 are higher in richer countries. This implies that the same quali-quantitative 
level of goods and services (output) requires a higher level of expenditure (input), determining a 
negative relationship between GDP and the efficiency scores. Furthermore, this represents an 
opposite finding with respect to the paper by Afonso e St. Aubyn (2011), that pins down a positive 
relationship between GDP and EFF. It is worth noticing, however, that their analysis is conducted 
in a pre-crisis time span (2003-2005). Thus, a further interpretation of our finding can be strictly 
linked to the down-turning phase of the economy (2007/2008 crisis). 
Turning to the second socio-economic variable (VAX65), we find a further negative correlation 
(strongly significant, at the 1% level). This category of treatment captures the heterogeneous 
attitude of individuals towards preventive health care in each country. The negative sign, however, 
could be interpreted as the limited effectiveness, in some periods, of this form of elderly people 
vaccine on life-expectancy, and on overall EFF. As pointed out in Hawkes (2017), flu vaccination 
programmes for the over-65s can be ineffective, as in the UK in 2016. This could be in line with 
                                                             
9
 See Mano and Castillo (2015). 
the recognition that: a) often the actual type of flu vaccines works less well with the elderly 
individuals (65+); b) costs could overwhelm benefits. 
Vaccinations overall, however, are indeed a main component of preventive medicine. As for 
vaccine for children (DTP), by contrast, we find a positive correlation with the efficiency scores 
(significant at the 10% level). This finding can be interpreted as a positive balance between input 
(i.e., HE) and output (i.e., ISR), due to the higher effectiveness displaced by DTP (often mandatory 
by law) on the children’s health status.  
Geographical localization effects, picked by the variable TEMP, have a positive sign and are 
significant (at the level 5%): relative warmer countries exhibit a higher life expectancy. 
As for the burden of administrative slowness (RT), we find the expected negative correlation 
(significant at the 10% level) with the efficiency scores. That is to say, the slowness of the 
bureaucracy in implementing public policies spreads in all sector of public intervention. The 
institutional framework efficiency, output being equal, enhances the expenditure (input) for the 
provision of health care services (see Cutler et al. 2012). 
In Model 2, we furtherly add life-style factors as control variables. TOB and OB are both 
significant and with the expected sign. In terms of robustness of the previous estimation results, 
all regressors present the same sign and remain statistically significant.  
In order to test the robustness of our results, table VIII reports the estimation results from the 
bootstrap procedure according to algorithm #1 from Simar and Wilson (2007), employing the same 
previous specifications (model 1 and 2) of the Tobit regression. Results are close to the Tobit ones, 
except for RT and OB, that are no longer significant. Even though with the same sign, the non-
significant result of bureaucratic red tape could be due to the more limited binding effect of 
administrative procedures on the emergency provisions of health care treatments. 
 
Table VIII: Bootstrap results. Dependent variable: FDH input-oriented efficiency scores 
Simar & Wilson (2007) Bootstrap algorithm #1 
 
Model 1 
FDH 
Model 2 
FDH 
TEMP 
0.0205710** 
(-0.0126) 
0.0223753*** 
(-0.00222) 
VAX65 
-0.00538710*** 
(-0.00713) 
-0.00639011*** 
(-0.000647) 
GDP 
-1.02257e-05*** 
(-1.24E-04) 
-1.09428e-05*** 
(-9.23E-06) 
DTP 
0.0156412 
(-0.199) 
0.0248569** 
(-0.0388) 
RT 
-0.0831456 
(-0.167) 
-0.0535543 
(-0.359) 
TOB  
-0.0160742** 
(-0.0259) 
OB  
-0.000221677 
(-0.962) 
Const. 
-0.766973 
(-0.543) 
-1.193989 
(-0.318) 
sigma 
0.113659*** 
(-3.83E-11) 
0.104321*** 
(-1.20E-11) 
Obs. 24 24 
Note: Robust standard errors in parentheses *** p<0.01, ** p<0.05, * p<0.1 
It is important to note that our primary regressors, TEMP, VAX65, GDP, DTP and TOB, apart from 
maintaining the same sign and in some cases reinforcing the statistical significance of the Tobit 
regression, show very similar magnitude of the coefficients across the two alternative estimation 
techniques. This evidence reinforces the robustness of our findings. 
 
5. Concluding remarks 
In this paper, we analysed health sector efficiency in 30 countries by assessing output (HPI, based 
on infant survival rates; life-expectancy at birth; and hospital discharge rates) against input (per 
capita public health expenditure) and non-discretionary factors (per capita GDP, weather 
temperature, vaccine coverage, smoking habits and obesity, burden of administrative procedures). 
We have applied both the DEA/Tobit procedure and the Simar & Wilson Bootstrap algorithm #1. 
Results are very similar in these different estimation processes, which increases confidence in their 
reliability. Results from the first part of the analysis show that inefficiency is significantly high: 
on average, countries could use around 30-40% less resources to attain the same outcomes, if they 
were fully efficient. Results from the second part of the analysis show that per capita GDP, vaccine 
coverage and tobacco consumption are highly significant and strongly correlated to efficiency, in 
all the model specifications. In addition, we also control for geographical and institutional 
variables. While weather temperature is positively correlated to the efficiency health care scores 
through its positive effect on LE, bureaucratic red tape seems to play a more ambiguous role, 
probably due to the smaller relevance of administrative procedures when dealing with the 
provision of emergency health care treatments. 
The findings obtained raise further policy implications. The enhancement of health sector 
efficiency cannot be obtained by a one-shot expenditure cut policy. It emerges that the complexity 
surrounding the multidimensional provision of health care services (i.e., preventive versus curative 
care, emergency versus ordinary care, elderly versus children) calls for a systematic and long-term 
approach. This is coherent with a paternalistic role of the State which is generally associated to a 
lower time preference rate with respect to individuals. The aim of enhancing care and clinical 
appropriateness should play a central role (see Mancuso et al. 2016). 
Particularly, besides the lifestyle factors, the role of preventive care vaccine is relevant in terms of 
structural policy implications. The results for DTP suggest specific long-term policies in order 
enhance the awareness on infant immunization. This topic is relevant in the socio-economic debate 
in Europe. In Italy, for instance, the recent Law 119/2017 introduced a compulsory vaccination 
mix for the primary and secondary school enrolment. This policy measure has been central in the 
last national political elections, furtherly generating distorted information. Therefore, this requires 
a greater effort on knowledge diffusion of scientific medical research. 
Findings obtained for VAX65 is counterintuitive. This is probably due to the interaction among 
different factors. Elderly individuals’ immunization is designed to displace a limited effectiveness 
typically in the short term. The positive expected effect of the vaccine, however, is not granted. 
On the one hand, the flu vaccines work less well in the elderly because of weaker immune systems 
with respect to younger individuals and it is effective a limited number of flu strains. On the other 
hand, the target population is heterogenous with respect to the individuals’ pathologies, requiring 
a greater attention to the appropriateness of this specific medical treatment. These considerations 
suggest that public policy should be addressed to increase the overall level of research and 
development investments to ensure an enhancement of the effectiveness of VAX65, improving the 
fine tuning with respect to flu strains. Moreover, public institutions could set down detailed 
guidelines to upgrade the appropriateness of this medical treatment for the elderly population. 
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